Clinical Trials
47 trialsECWHCCFLACC
First Affiliated Hospital of Guangxi Medical University
Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.
Shandong Public Health Clinical Center
Efficacy and Safety of Sintilimab Combined with Nab-PP Plus Rh-endostatin in Locally Advanced/advanced and Recurrent Metastatic Squamous Non-small Cell Lung Cancer: a Single-arm, Multicenter Clinical Study
Second Affiliated Hospital of Zunyi Medical University
Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas
Beijing Sanbo Brain Hospital
Modified CV Regimen in Optic Pathway Glioma
Beijing Sanbo Brain Hospital
Local Injection and Systemic Therapy in the Treatment of NSCLC.
Henan Cancer Hospital
GEP Combined With Radiotherapy in Non-locally Treatable Recurrent NPC
Zhejiang Cancer Hospital
Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors
Nanjing First Hospital, Nanjing Medical University
Recombinant Human Endostatin Combined With Envafolimab and Synchronal Radiochemotherapy
The First Affiliated Hospital of Xinxiang Medical College
A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor in Combination With PRaG for Advanced Refractory Non-small Cell Lung Cancer
Second Affiliated Hospital of Soochow University
Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal Cancer
Sun Yat-sen University
FTANLCNDG
Qianfoshan Hospital
Envafolimab Combined With Endostatin in Recurrent or Metastatic MSS-type Colorectal Cancer
First Affiliated Hospital Xi'an Jiaotong University
Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer
Anhui Chest Hospital
Radiotherapy Combined With Endostatin and Capecitabine for NPC
Zhejiang Cancer Hospital
Recombinant Human Angioendostatin /PD-1 Mab Combined With First-line Chemotherapy in the Treatment of Driver Gene Negative Advanced NSCLC
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
A Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLC
Second Xiangya Hospital of Central South University
Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer
The Affiliated Hospital of Xuzhou Medical University
Envafolimab Combined With Chemotherapy and Recombinant Human Endostatin in the First-line Treatment of Sq-NSCLC
Qilu Hospital of Shandong University
Endostar for Locally Recurrent Nasopharyngeal Carcinoma
Sun Yat-sen University
SLICER
Peking University
Endostar Combined With Chemotherapy for Stage â…£ Soft Tissue Sarcoma
Tianjin Medical University Cancer Institute and Hospital
CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer
Zhejiang Cancer Hospital
Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal Carcinoma
Jiangsu Cancer Institute & Hospital
Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer
Zhejiang Cancer Hospital
A Trial of Endostar in Patients With Carcinoma of the Head and Neck
China International Medical Foundation
A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC
Sun Yat-sen University
Recombinant Human Endostatin (EndostarTM) Injection in Treatment of Recurrent Metastatic Breast Cancer
Xinjiang Medical University
Recombinant Human Endostatin(Rh-endostatin) Combine With Radiotherapy in the Treatment of Hepatocellular Carcinoma(HCC)
Chinese PLA General Hospital
Endostar First-line Treatment of Advanced NSCLC
China Medical University, China
Chemotherapy Plus Endostatin in Advanced Pancreatic Neuroendocrine Tumor
Peking Union Medical College Hospital
Rh-endostatin in Combination With Dacarbazine and Cisplatin as the First Line Therapy for Metastatic Melanoma
Peking University Cancer Hospital & Institute
Endostatin
Beijing Tiantan Hospital
Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Endostatin in Combination With Oxaliplatin and Radiotherapy in Esophageal Cancer Patients.
Hangzhou Cancer Hospital
Trial of Endostar Combined With CHOPT for T Cell Lymphoma
Tianjin Medical University Cancer Institute and Hospital
Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations
Zhejiang University
Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital
Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC
Zhejiang University
Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultrasonography
Sun Yat-sen University
Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer
ChineseAMS
Endostar + GT in Pulmonary Metastases of Soft Tissue Sarcoma
ChineseAMS
DP-EN-RT
Sun Yat-sen University
Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer Patients
Fudan University
Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)
Zhejiang Cancer Hospital
Neoadjuvant Endostatin and Chemotherapy for Breast Cancer
Xijing Hospital
FOLFOX4 Combined With Endostar in Patients With Advanced Colorectal Cancer
Simcere Pharmaceutical Co., Ltd